Adipose-Derived Stem Cells for Regenerating Insulin-Producing Cells: An Innovative Therapeutic Strategy for Diabetes

Diabetes mellitus is a major global health concern, affecting millions of people. Existing treatments, including as insulin injections and oral medicines, assist manage symptoms but do not replace destroyed insulin-producing β cells. In recent years, regenerative medicine has developed as a fresh method to treating the underlying causes of diabetes. Among the many types of stem cells. Adipose-derived stem cells (ADSCs) are distinguished by their ease of extraction, quantity, and capacity to differentiate into insulin-secreting cells. This page covers how ADSCs can replenish β-cells, their basic mechanisms, available preclinical and clinical data, and future difficulties and directions. Notably, certain clinical instances from China demonstrated substantial improvements, including total independence from diabetic treatment. These findings provide hope for a long-term treatment to diabetes using cellular therapy.